Mechanisms of a novel regulatory light chain–dependent cardiac myosin inhibitor
Kristina B. Kooiker(California Institute for Regenerative Medicine), Michael Regnier(University of Washington), Na Sa(Bristol-Myers Squibb (Germany)), Thomas C. Irving(Illinois Institute of Technology), Weikang Ma(Biocat), Farid Moussavi‐Harami(California Institute for Regenerative Medicine), Anthony Asencio(University of Washington), Timothy S. McMillen(Anna Needs Neuroblastoma Answers), Galina Flint(Mahindra and Mahindra Limited (India)), Devin Nissen(Illinois Institute of Technology), Chengqian Gao(Dalian Medical University), Saffie Mohran(University of Washington), Ming Yu(Bristol-Myers Squibb (Germany)), Stephanie Neys(University of Washington), Qing-Fen Gan(La Roche College), Yuanhua Cheng(University of Washington)
Cited by 3
Related Papers
Selective Elimination of Human Pluripotent Stem Cells by an Oleate Synthesis Inhibitor Discovered in a High-Throughput Screen
|Cell stem cell|2013|307
Dietary Cholesterol Worsens Adipose Tissue Macrophage Accumulation and Atherosclerosis in Obese LDL Receptor–Deficient Mice
|Arteriosclerosis Thrombosis and Vascular Biology|2008|181
Ablation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes
|Journal of Molecular and Cellular Cardiology|2016|152
Physiological Mitochondrial Fragmentation Is a Normal Cardiac Adaptation to Increased Energy Demand
|Circulation Research|2017|143